Skip to content
Home/Companies/Biotech/S-Biomedic
SB

S-Biomedic

Biotech·Belgium·Exited 2022·Held 4yr

S-Biomedic is a biotech company, headquartered in Belgium.

Entry
2018
Hold
4yr
Exit
2022
Est. EV
–

Who owns S-Biomedic?

S-Biomedic was owned by Oscar & Paul (Beiersdorf Venture Capital) through Oscar & Paul Venture Capital Fund I (2020 vintage) from 2018 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Oscar & Paul (Beiersdorf Venture Capital)
Investor
Oscar & Paul (Beiersdorf Venture Capital)
Oscar & Paul Venture Capital Fund I · 2020 · VC

Key facts

HQBelgium
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Oscar & Paul Venture Capital Fund I

Other portfolio companies in the same fund.

Turbine
Active
Deep TechUnited Kingdom· 2026
Cellvie
Active
BiotechUnited States· 2025
Melt&Marble
Active
BiotechSweden· 2025
ReVentas
Active
EnergyUnited Kingdom· 2025
Vincere Biosciences
Active
BiotechUnited States· 2025
DeepLife
Active
Deep TechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings